LYME DISEASE DIAGNOSTICS MARKET ANALYSIS

Lyme Disease Diagnostics Market, by Diagnostics Test (Enzyme Linked Immunosorbent Assay, Western Blot, and Others), by End User (Hospitals, Clinics, and Diagnostic Laboratories) and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1608
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Lyme Disease Diagnostics Market Competitive Analysis

Major players operating in the Lyme disease diagnostics market include Abbott Laboratories, Affymetrix Inc., Alere Inc., Baxter International Inc., Bio-Rad Laboratories, Boulder Diagnostics, Canon Life Sciences, Covance Inc., Fresenius Medical Care AG & Co., GlaxoSmithKline Pharmaceuticals Ltd., Roche Diagnostics International Ltd., Siemens AG, and T2 Biosystems, Immunetics Inc. Key players in the market are focusing on developing new diagnostic tools, in collaboration with government organizations or research institutes or by themselves.